Evolent Health Statistics
Share Statistics
Evolent Health has 120.58M shares outstanding. The number of shares has increased by 1.16% in one year.
| Shares Outstanding | 120.58M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.07% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 111.83M |
| Failed to Deliver (FTD) Shares | 93 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 12.49M, so 10.71% of the outstanding shares have been sold short.
| Short Interest | 12.49M |
| Short % of Shares Out | 10.71% |
| Short % of Float | 11.17% |
| Short Ratio (days to cover) | 7.7 |
Valuation Ratios
The PE ratio is -32.51 and the forward PE ratio is 10.1.
| PE Ratio | -32.51 |
| Forward PE | 10.1 |
| PS Ratio | 1.87 |
| Forward PS | 0.5 |
| PB Ratio | 3.44 |
| P/FCF Ratio | 32.28 |
| PEG Ratio | n/a |
Enterprise Valuation
Evolent Health Inc. has an Enterprise Value (EV) of 4.13B.
| EV / Earnings | -36.51 |
| EV / Sales | 2.1 |
| EV / EBITDA | -166.5 |
| EV / EBIT | -57.95 |
| EV / FCF | 36.25 |
Financial Position
The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.57.
| Current Ratio | 1.01 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.57 |
| Total Debt / Capitalization | 36.24 |
| Cash Flow / Debt | 0.23 |
| Interest Coverage | -1.31 |
Financial Efficiency
Return on equity (ROE) is -0.11% and return on capital (ROIC) is -2.32%.
| Return on Equity (ROE) | -0.11% |
| Return on Assets (ROA) | -0.04% |
| Return on Capital (ROIC) | -2.32% |
| Revenue Per Employee | 417.85K |
| Profits Per Employee | -24.05K |
| Employee Count | 4.70K |
| Asset Turnover | 0.73 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -89.36M |
| Effective Tax Rate | 0.44 |
Stock Price Statistics
The stock price has increased by -62.56% in the last 52 weeks. The beta is 1.59, so Evolent Health 's price volatility has been higher than the market average.
| Beta | 1.59 |
| 52-Week Price Change | -62.56% |
| 50-Day Moving Average | 18.74 |
| 200-Day Moving Average | 24.74 |
| Relative Strength Index (RSI) | 32.35 |
| Average Volume (20 Days) | 2.52M |
Income Statement
In the last 12 months, Evolent Health had revenue of $1.96B and earned -$113.04M in profits. Earnings per share was $-1.28.
| Revenue | 1.96B |
| Gross Profit | 460.47M |
| Operating Income | -71.21M |
| Net Income | -113.04M |
| EBITDA | -24.79M |
| EBIT | -71.21M |
| Earnings Per Share (EPS) | -1.28 |
Balance Sheet
The company has $192.82M in cash and $644.80M in debt, giving a net cash position of -$451.97M.
| Cash & Cash Equivalents | 192.82M |
| Total Debt | 644.80M |
| Net Cash | -451.97M |
| Retained Earnings | -719.19M |
| Total Assets | 2.50B |
| Working Capital | 20.33M |
Cash Flow
In the last 12 months, operating cash flow was $142.58M and capital expenditures -$28.75M, giving a free cash flow of $113.84M.
| Operating Cash Flow | 142.58M |
| Capital Expenditures | -28.75M |
| Free Cash Flow | 113.84M |
| FCF Per Share | 1.02 |
Margins
Gross margin is 23.45%, with operating and profit margins of -3.63% and -5.76%.
| Gross Margin | 23.45% |
| Operating Margin | -3.63% |
| Pretax Margin | -10.31% |
| Profit Margin | -5.76% |
| EBITDA Margin | -1.26% |
| EBIT Margin | -3.63% |
| FCF Margin | 5.8% |
Dividends & Yields
EVH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -11.27% |
| FCF Yield | 8.31% |
Analyst Forecast
The average price target for EVH is $24.5, which is 115.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $24.5 |
| Price Target Difference | 115.7% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Scores
| Altman Z-Score | 1.05 |
| Piotroski F-Score | 5 |